Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Novel Microbe Biomarkers Reveal Evidence of Radiation Exposure

By LabMedica International staff writers
Posted on 14 Jun 2012
Researchers have identified unique biomarkers that could be used to confirm exposure to damaging radiation in large groups of individuals potentially exposed to unknown and variable doses for the purpose of triage and treatment.

The findings are published in the May 1, 2012, issue of the journal Radiation Research. More...
John E. Baker, PhD, professor of surgery, biochemistry, pharmacology, and toxicology at the Medical College of Wisconsin (Milwaukee, USA), is the lead author of the study.

There is an urgent need for fast, precise, and sensitive diagnostic platforms to validate exposure to radiation and estimate the dose absorbed by individuals. Clinical symptoms do not provide sufficient diagnostic information to triage and treat life-threatening radiation injuries; furthermore, the United States has been found to be unprepared to assess and triage large groups of patients with potential radiation exposure.

In this study, researchers examined the microbes found in rat feces before and after exposure to radiation. Alterations were identified in the levels of 212 genomically unique bacteria, of which 59 are found in humans. Those changes persisted at least 21 days following the exposure to radiation. One particular type of microbe, Proteobacteria, increased nearly 1,000- fold four days following irradiation.

“If there were to be a radiological terrorism scenario, there could be hundreds of thousands of people that would be present around the ground zero area, and limited medical resources available to evaluate their exposure levels,” explained Dr. Baker. “Analyzing microbial signatures in those patients would be a noninvasive way to obtain results in a timely fashion, and allow us to commit resources to patients in need of intervention.”

The PhyloChip assay, developed by Second Genome (San Bruno, CA, USA), was used in this study to examine specific bacterial taxa.

Related Links:

Medical College of Wisconsin



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.